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Abstract
Purpose
X-ray coronary angiography (XCA) is the current gold standard for the assessment of lumen
encroaching coronary stenosis but XCA does not allow for early detection of rupture-prone
vulnerable plaques, which are thought to be the precursor lesions of most acute myocardial
infarctions (AMI) and sudden death. The aim of this study was to investigate the potential of
delayed contrast-enhanced magnetic resonance coronary vessel wall imaging (CE-MRCVI)
for the detection of culprit lesions in the coronary arteries.
Methods
16 patients (13 male, age 61.9±8.6 years) presenting with sub-acute MI underwent CE-
MRCVI within 24-72h prior to invasive XCA. CE-MRCVI was performed using a T1-weighted
3D gradient echo inversion recovery sequence (3D IR TFE) 40±4 minutes following the
administration of 0.2 mmol/kg gadolinium-diethylenetriamine-pentaacetic acid (DTPA) on a
3T MRI scanner equipped with a 32-channel cardiac coil.
Results
14 patients were found to have culprit lesions (7x LAD, 1xLCX, 6xRCA) as identified by
XCA. Quantitative CE-MRCVI correctly identified the culprit lesion location with a sensitivity
of 79% and excluded culprit lesion formation with a specificity of 99%. The contrast to noise
ratio (CNR) of culprit lesions (9.7±4.1) significantly exceeded CNR values of segments with-
out culprit lesions (2.9±1.9, p<0.001).
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Conclusion
CE-MRCVI allows the selective visualization of culprit lesions in patients immediately after
myocardial infarction (MI). The pronounced contrast uptake in ruptured plaques may repre-
sent a surrogate biomarker of plaque activity and/or vulnerability.
Introduction
Despite improvements in prevention, diagnosis and treatment, cardiovascular disease remains
the leading cause of morbidity and mortality in Western industrialized nations and in develop-
ing countries. Whereas atherosclerosis alone is rarely fatal, sudden luminal thrombosis, super-
imposed on a ruptured or eroded atherosclerotic plaque, precipitates life threatening clinical
events such as acute coronary syndromes and stroke [1–3]. Plaques thought to cause luminal
thrombosis are referred to as vulnerable plaques. Histologically these types of plaques in most
cases are so-called thin-cap fibroatheromas (TCFA). TCFAs are characterized by a large lipid
or necrotic core separated from the coronary arterial lumen by a thin membrane cap [4].
Although various clinical studies using conventional invasive coronary angiography, intra-vas-
cular ultrasound (IVUS), and cardiac computed tomography[5–7] have confirmed a strong
relationship between atherosclerotic disease burden and risk for adverse events, there is no
conclusive evidence that individual plaque assessment improves the prediction of acute coro-
nary event risk compared to established risk factors, such as the extent and severity of coronary
artery disease [8,9].
Because of its noninvasiveness, excellent soft-tissue contrast and ability to visualize the cor-
onary lumen and vessel wall, magnetic resonance imaging (MRI) is a very promising imaging
modality to assess coronary lumen integrity[10,11], atherosclerotic disease burden[12–21],
plaque activity and composition[22–27]. Compared to native coronary MR vessel wall imag-
ing[28,29], contrast-enhanced MR coronary vessel wall imaging (CE-MRCVI) is faster and
potentially more robust, offering morphological as well as functional assessment of atheroscle-
rotic plaque formation[30,31].
The aim of this study was to investigate the potential of CE-MRCVI for the characterization
of culprit lesions in patients with high prevalence and known plaque vulnerability prior to
invasive assessment and interventional treatment.
Methods
Study population
The study was approved by the local research ethics committee (Guy’s NHS Research Ethics
Committee London, UK, Study No. 08/H0802/101). Written informed consent was obtained
from all patients before inclusion into the trial. Participants in this study were recruited
between June 2008 and January 2010. Sixteen patients with acute myocardial infarction were
prospectively enrolled within 72 hours (45.1±22.6 hours) after initial onset of symptoms, who
were not eligible for primary percutaneous coronary intervention. The mean age of partici-
pants was 61.9 years with an age range from 46 to 75 years. This included patients with non-
ST-elevation acute coronary syndromes and those who had received thrombolysis for ST-
elevation myocardial infarction. The diagnosis of acute myocardial infarction was based on
elevation of cardiac biomarkers with at least one of the following: Electrocardiogram changes
indicative of novel ischemia or development of pathologic Q-waves, symptoms of ischemia.
CE-MRCVI in AMI
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Patients which were eligible for primary percutaneous coronary intervention, patients with
clinical or electrocardiogram evidence of ongoing ischemia, significant cardiac arrhythmia
and/or heart failure (New York Heart Association IV) were not included. Additional exclusion
criteria were: < eighteen years of age, patients unable to give consent, impaired renal function
(glomerular filtration rate less than 30 ml per min) mental disorders, contraindications to
iodine or gadolinium, claustrophobia, breastfeeding or pregnancy. Within 24h (median 4.5 h;
range 1–26 h) prior to invasive x-ray coronary angiography, the majority of patients (n = 15)
were scanned successfully. Patients received glycoprotein 2b/3a inhibitors or stenting during
x-ray coronary angiography depending on the interventional cardiologist.
Magnetic resonance imaging, X-ray coronary angiography and culprit
lesion definition
All participants were investigated on a clinical 3T magnetic resonance imaging (MRI) scanner
(Achieva, Philips Healthcare, Best, the Netherlands) in a supine position. The scanner was
equipped with a specific cardiac coil (32 channels, InVivo Corporation, USA) in combination
with a specific software package for cardiovascular imaging. Patients were monitored with a
four-lead electrocardiogram, an oxygenation sensor to assess blood oxygen levels and a respi-
ratory belt. Before the image acquisition was started diethylenetriamine-pentaacetic acid (0.2
mmol/kg DTPA, Magnevist, Bayer-Schering, Berlin, Germany) was administered via an intra-
venous access. First the coronary arteries were localized. Then a 3D T2-prepared fast GRE
(gradient echo) sequence was acquired. In the next step the three point planscan tool was used
to define acquire imaging planes parallel of the right and left coronary artery system. Subse-
quently a coronary magnetic resonance angiography (coronary MRA) was performed using a
3D T2prep fast GRE (TFE) sequence [32]. Imaging parameters of the sequence were: number
of slices = 20, acquired in-plane resolution = 1.25 x 1.25 mm, reconstructed slice thickness = 1.5
mm (acquired: 3 mm), acquisition matrix = 256 x 256, field of view = 320 x 320 mm, acquisi-
tion window = 80 to 100 ms, flip angle = 20 degrees, repetition time = 5.5 ms, echo time 1.7
ms, and startup cycles = 5. Contrast enhanced (CE) imaging of the coronary artery wall was
started 31 min (mean time 31.2 minutes, range 26.5 to 34.7 minutes) following the administra-
tion of diethylenetriamine-pentaacetic acid. A T1-weighted fat-suppressed (FS) 3D GRE inver-
sion recovery (3D IR TFE) MR sequence was used. The main imaging parameters, including
the orientation of the imaging sequence as well as the spatial resolution were identical to the
initially performed coronary MRA. Differences existed regarding the flip angle = 30 degrees,
repetition time = 5.7 ms, the echo time = 1.8 ms; additionally, an adiabatic (nonselective)
inversion radiofrequency pulse was used instead of the T2 preparation pulse. The sequence
was ECG-triggered and navigator-gated. The exact sequence design was also described in a
previous publication[26]. The inversion time of the scan (median 230, range 180 to 280 ms)
was specifically adjusted to minimize signal from the blood on a patient by patient basis. To
achieve an optimal nulling off signal from the blood a region of interest was used on the look
locker sequence to calculate the most precise inversion time. Based on the information avail-
able from the twelve lead electrocardiogram, the most likely affected coronary vessel system
was scanned first. X-ray coronary angiography was performed using standard techniques with
multiple projections. The culprit lesion was defined as the site with the smallest diameter [33].
Analysis of magnetic resonance imaging and X-ray coronary
angiography
As described in previous publications a specific postprocessing tool (soapbubble) was used to
reform eight data sets and to analyze the coronary magnetic resonance angiography as well as
CE-MRCVI in AMI
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the contrast-enhanced images[34]. To compare magnetic resonance imaging to x-ray angiog-
raphy a previously described eight segment model was used[26]. The coronary angiography
was analyzed by two interventional cardiologists (DP, SR) with extensive experience. The
length of the coronary artery vessel wall of each segment was quantified as performed in a pre-
vious study[32]. Coronary artery segments in which a stent was present as well as segments
distal to stents were specifically excluded from the analysis. This was due to the inadequate
suppression of signal from blood in these segments because of Faraday shielding effects and
susceptibility artifacts. To visualize the colocalization of the coronary artery wall enhancement
with regards to the course of the coronary arteries, the coronary magnetic resonance angiogra-
phy and the contrast-enhanced images were automatically fused using a DICOM viewer
(OsiriX, Geneva, Switzerland, Fig 1).
Findings were classified into three categories: 1st “normal” coronary segments without visu-
ally apparent culprit lesion formation, 2nd affected coronary segments with visually apparent
culprit lesion formation and 3rd segmented culprit lesion. Contrast-to-noise ratio (CNR) of
“normal” coronary segments was determined by manual segmentation of the normal segment
including coronary vessel wall and blood as described previously (Fig 1D) [30]. In case of visu-
ally apparent culprit lesion formation, affected coronary segment was manually segmented
and affected coronary segment SNR including mean signal of blood, vessel wall and culprit
lesion was calculated. Culprit lesion CNR was determined by manual segmentation of visually
apparent culprit lesion area (Fig 1E). Noise (N) was determined in a ROI placed in the lung
with the exclusion of areas with visible vascularization. Contrast-to-noise ratio (CNR) was
measured between coronary (SIcoronary-vessel-wall) and aortic blood signal. The CNR was calcu-
lated by the following formula: CNR = (SI coronary-vessel-wall − SIblood))/N.
Relative CNR values were calculated as ratio between visually apparent culprit lesion area,
area of the entire affected coronary segment (including culprit lesion formation) or area of
“normal” segments without culprit lesion and the averaged CNR of the corresponding entire
left or right coronary system. To account for variation in signal intensity across the FOV due
to spatial variation of the coil sensitivity an automatic correction for coil sensitivity (CLEAR)
was applied. Relative CNR value measurements were repeated to calculate the intraobserver
and interobserver variabilities. Two observers analyzed data of a subset of 10 patients in an
independent manner, blinded to the angiography.
Statistical analysis
The statistical analysis in this study was performed using SAS 9.2 (SAS Institute Inc., Cary,
USA) and PASW Statistics software 18.0.0 (SPSS Inc, Chicago). Values were reported as
mean ± with a 95% confidence interval (CI), mean ± standard deviation. If values were not
normally distributed and they were reported as median ± range. For the comparison of contin-
uous values a paired student’s t-test was performed. For the comparison of categorical values a
Wilcoxon signed rank test was performed. P values lesser than 0.05 were considered signifi-
cant. Per segment comparisons were performed, which were not independent of each other.
To statistically correct for that, segments with and without culprit lesions, adjacent coronary
segments of the same artery or coronary system were tested using repeated measures mixed
linear models including compound symmetry as working correlation matrix to account for mul-
tiple measurements. Regarding the comparison of contrast to noise ratio differences of the differ-
ent groups mixed model with t-tests was applied. Relative CNR value measurements were
repeated to calculate the intraobserver and interobserver variabilities. Two observers analyzed
data of a subset of ten patients in an independent manner and blinded to the angiography. To
determine the cutoff values for CNRs (relative and absolute) between segments without culprit
CE-MRCVI in AMI
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lesions and with culprit lesions, receiver-operating characteristics (ROC) curves were used. To
determine the best cutoff value, the Youden-index was used.
Results
Patients characteristics
Table 1 summarizes the patient characteristics of the investigated study population. A total of
16 patients (13 men, age 61.9±8.6) with: 1) anterior STEMI (n = 7), 2) inferior STEMI (n = 7)
and 3) NSTEMI (n = 2), were included in this study. At the time of inclusion all patients had
no clinical or ECG evidence of ongoing ischemia. CMR scans were performed within 72 hours
(median 45.2h, 8.3–70.8h) after onset of symptoms. Patients with anterior STEMI had a higher
TIMI Risk Score (7.3 vs. 2.2, p = 0.027) and were older (age 66.8±8.0 vs. 58.5±8.0) as compared
Fig 1. CE-MRCVI findings in a patient with troponin positive ACS in the RCA. Coronary MRA (A) of a 48-year-old male with troponin positive ACS
showed decreased vessel lumen size of the mid RCA (red arrows). To highlight the relationship between CE-MRCVI (B) and morphology (A), images were
fused in a way similar to PET/CT (C). CE-MRCVI displays high signal intensity (red arrows) within the mid RCA. Analysis of signal enhancement on
CE-MRCVI (E, red) suggestive for culprit lesion yielded a contrast-to-noise ratio (CNR) of 12.7. Corresponding XCA (F) confirmed CE-MRCVI findings
with mid RCA de-novo lesion (pre-treatment stenosis of 75–94%). MRA: magnetic resonance angiography, CE-MRCVI: contrast enhanced magnetic
resonance coronary vessel wall imaging, PET/CT: positron emission tomography/computed tomography. CE-MRCVI:contrast enhanced magnetic
resoance coronary vessel wall imaging, ACS: acute coronary syndrome, RCA: right coronary artery, MRA: magnetic resonance angiography, XCA: x-ray
coronary angiography, PET/CT: positron emission tomography/computed tomography.
https://doi.org/10.1371/journal.pone.0188292.g001
CE-MRCVI in AMI
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to patients with inferior STEMI. The incidence of failed thrombolysis (n = 7, thrombolysis for
STEMI with ST resolution >90min) was identical in both groups.
Findings on x-ray coronary angiography
X-ray coronary angiography findings of the study population are summarized in Tables 2 and
3. XCA was performed within the following day after CE-MRCVI (median 4.5 h; range 1–26
h). In 14 of 16 patients a culprit lesion was identified by XCA and located in the left anterior
descending artery (LAD, n = 7), left coronary artery (LCX, n = 2) and right coronary artery
(RCA, n = 5) (Table 3). In one patient (Table 3—Patient 4) XCA revealed marked proximal
ectasia of all the major coronary vessels without obvious culprit lesion. The posterior left ven-
tricular artery (PLV) branch of the dominant RCA was occluded with a heavy thrombus load
and filled retrograde from the left. The posterior descending artery (PDA) ostium also showed
heavy thrombus burden, but flow was preserved (TIMI III flow). In the other patient (Table 3
—Patient 13) with symptoms of ischemia, inferior ST segment elevation and positive cardiac
necrosis markers, XCA showed non-stenotic coronary arteries after failed thrombolysis.
Table 1. Baseline characteristics of patients with acute myocardial infarction. Characteristics of patients with acute myocardial infarction, including
patients with anterior and inferior STEMI. Characteristics include typical risk factors, laboratory findings, TIMI risk score and GRACE risk score.
Patient with acute myocardial
infarction
n = 16
Patients with anterior
STEMI
n = 7
Patients with inferior
STEMI
n = 7
p
Age (years) 61.3 ± 8.6 66.8 ± 8.0 58.5 ± 8.0 0.03
Male, n (%) 13 (81%) 5 (71%) 6 (86%) ns
Weight (kg) 78.8 ± 13.9 75.6 ± 15.6 75.6 ± 11.9 ns
BMI 26.1 ± 3.1 25.5 ± 2.2 24.9 ± 3.4 ns
Median Risk factors, n 2 2 3 ns
Hypercholesterolaemia, n (%) 12 (69%) 5 (71%) 5 (71%) ns
Hypertension 9 (56%) 6 (86%) 3 (43%) ns
Diabetes mellitus 2 (13%) 2 (29%) 0 (2%) ns
Smoking 8 (50%) 3 (43%) 4 (57%) ns
Family history of CAD 7 (44%) 3 (43%) 3 (43%) ns
Medical history of coronary artery stenting 1 (7%) 1 (17%) 0 (0%) ns
ST-Segment Elevation Myocardial Infarction
(STEMI)
14 (88%) 7 (100%) 7 (100%) ns
Anterior STEMI 7 (44%)
Failed thrombolysis 12 (75%) 6 (86%) 6 (86%) ns
Median Blood pressure, mmHg
Systolic, mmHg 115 120 105 ns
Diastolic mmHg 73 65 65 ns
Median Heart rate, bpm 69 75 67 ns
Laboratory findings
Troponin T, ng/ml 2.0 (0.2–8.0) 1.0 (0.2–5.2) 2.1 (0.6–7.4) ns
Leucocytes, 10E9 10.8 (5.8–35.0) 9.3 (6.1–15.4) 12.4 (11.7–18.1) ns
C-reactive protein, mg/dl 9.0 (< 5–60) 7.5 (6.0–9.0) 8.0 (2.5–60.0) ns
Platelets, 10E9 227 (160–653) 235 (160–328) 228 (168–653) ns
TIMI Risk Score, %Death or MI 4.4 (1.6–23.4) 7.3 (2.2–23.4) 2.2 (1.6–7.3) 0.027
GRACE Risk Score, %Death or MI
In-Hospital 18 (7–29) 18 (15–29) 19 (14–22) ns
6 month follow up 31.0 (13–40) 31 (25–40) 34 (22–37) ns
https://doi.org/10.1371/journal.pone.0188292.t001
CE-MRCVI in AMI
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Although late gadolinium MR images did not show a typical mid myocardial scarring, recent
medical history and CRP increase up to 60 mg/l suggest myocarditis as the most likely cause
for ECG changes and troponin rise.
CE-MRCVI
CE-MRCVI scans were successfully performed in all 16 subjects. In one patient (Table 3—
Patient 16) with sub-acute STEMI, only CE-MRCVI of the left coronary artery (LCA) was
obtained due to patient discomfort. A total of 119 (95% of available segments) were analyzed
for coronary vessel wall enhancement.
CE-MRCVI—Visual assessment
CE-MRCVI fused with coronary MRA (Fig 1) showed localized marked signal increase of the
vessel wall in all 14 patients with culprit lesion formation on XCA (7 LAD, 2 LCX and 5 RCA).
CE-MRCVI findings are summarized in Table 3. In the patient (Table 3—Patient 4) with
marked proximal ectasia of all the major coronary vessels, CE-MRCVI did not show any cir-
cumscribed signal increase of the proximal, mid or distal RCA vessel wall. Based on XCA
assessment, the proximal ectatic RCA segment in this patient was thought to be the most likely
source of in-situ thrombus of the PLV branch and PDA ostium. These distal branches, which
are not included in the 8-segment model, were not covered by the MRDTI scan.
Table 2. Angiographic findings in patients with acute myocardial infarction. Overview of patients with acute myocardial infarction, anterior STEMI, infe-
rior STEMI and NSTEMI. Detailed description of angiographic findings including the degree of stenosis for the number of segments.
Patient with acute myocardial
infarction
n = 16
Patients with anterior
STEMI
n = 7
Patients with inferior
STEMI
n = 7
Patients with
NSTEMI
n = 2
Vessel with disease, % (n)
"normal" vessels 14% (1/7) † 0% (0/7) 14% (1/7) † 0% (0/2)
1 vessel disease 38% (6/16) 43% (3/7) 43% (3/7) 0% (0/2)
2 vessel disease 44% (7/16) 43% (3/7) 29% (2/7) 100% (2/2)
3 vessel disease 13% (2/16) 14% (1/7) 14% (1/7) 0% (0/2)
Angiographic findings, % (n)
"Normal"
Segments
64.8% (83/128) 62.5% (35/56) 67.9 (38/56) 62.5 (10/16)
Segments 1% to
49%
4.7% (6/128) 3.6% (2/56) 3.6% (2/56) 0.0 (0/16)
Segments 50% to
74%
6.3% (8/128) 7.1% (4/56) 7.1% (4/56) 0.0 (0/16)
Segments 75% to
94%
13.3% (17/128) 16.1% (9/56) 5.4% (3/56) 31.3 (5/16)
Segments 95% to
99%
3.9% (5/128) 7.1% (4/56) 1.8% (1/56) 0.0 (0/16)
Complete
Occlusion
7.0% (9/128) 3.6% (2/56) 10.7% (6/56) 6.3 (1/16)
Culprit lesion location,
% (n) #
RCA 43.8% (7/16) 0.0% (0/7) 85.7% (6/7) 50.0% (1/2)
LAD 43.8% (7/16) 85.7% (6/7) 0.0% (0/7) 50.0% (1/2)
LCX 6.3% (1/16) 14.3% (1/7) 0.0% (0/7) 0.0% (0/2)
Lesions were considered hemodynamically important when they caused50% reduction of coronary luminal diameter
† One patient with inferior STEMI and tenecteplase thrombolysis was diagnosed with non obstructed coronary arteries in XCA
https://doi.org/10.1371/journal.pone.0188292.t002
CE-MRCVI in AMI
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CE-MRCVI—Absolute CNR
In patients shortly after MI signal intensity of coronary culprit lesion formation as measured
by CNR (n = 14, CNR 9.7±4.1) was significantly increased compared to the CNR averaged
over coronary segments with (n = 14, CNR 4.6±2.6, p<0.001) and without (n = 105, CNR 2.9
±1.9, p<0.001) culprit lesion formation (Fig 2). Based on a ROC curve analysis, a CNR thresh-
old of 6.3 was determined for the detection of culprit lesions in patients with sub-acute myo-
cardial infarction (segment-wise analysis: area under the curve 0.967, sensitivity 86%,
specificity 91%). Based on this cut-off value quantitative CE-MRCVI correctly identified the
culprit lesion location in 12 out of 14 patients, but resulted in 9 false positive segments (1 RCA,
1 LMS, 2 LAD, 5 LCX). The majority of these misclassified segments (7 out of 9) occurred
within the affected vascular system, resulting in 5 patients with multiple culprit lesions. All
Table 3. Diagnostic accuracy of CE-MRCVI culprit lesion location in comparison to XCA. This table gives an overview about the angiographic findings,
ECG findings as well as the absolute and relative CNR value for each of the investigated patients.
XCA ECG Visual
Assessment
Absolute Values (CNR) Relative CNR Values (%CNR)
Affected
System*
Affected
Segment
Culprit
lesion
Affected
System*
Affected
Segment
Culprit
lesion §
Patient 1 RCA 2 inferior
STEMI
RCA 2 3.5 (3.0–4.1) 5.7 13.8 83% (70–96%) 134% 323%
Patient 2 RCA 2 inferior
STEMI
RCA 2 2.4 (2.3–2.4) 2.6 6.5 97% (95–98%) 107% 264%
Patient 3 RCA 2 NSTEMI RCA 2 1.7 (1.3–2.1) 4.9 12.7 63% (46–77%) 177% 460%
Patient 4 PLV/
PDA†
inferior
STEMI
none
Patient 5 LCX 11 inferior
STEMI
LCX 11 2.0 (0.6–2.8) 3.2 10.1 94% (29–
131%)
151% 406%
Patient 6 LAD 6 anterior
STEMI
LAD 6 1.6 (1.4–2.3) 3.2 5.3 82% (68–
112%)
157% 236%
Patient 7 RCA 2 inferior
STEMI
RCA 2 0.8 (0.6–0.9) 1.2 6.4 83% (68–98%) 134% 694%
Patient 8 RCA 2 inferior
STEMI
RCA 2 0.6 (0.4–0.9) 2.6 6.5 49% (30–69%) 201% 495%
Patient 9 LAD 6 anterior
STEMI
LAD 6 3.4 (2.9–5.3) 4.8 10.4 85% (74–
135%)
121% 239%
Patient
10
LAD 7 NSTEMI LAD 7 6.3 (4.3–6.6) 6.3 9.2 105% (72–
111%)
106% 151%
Patient
11
LAD 7 anterior
STEMI
LAD 7 5.3 (2.7–6.5) 5.7 7.9 104% (53–
126%)
112% 138%
Patient
12
CX 11 anterior
STEMI
CX 11 4.4 (3.9–8.2) 10.4 20.3 71% (63–
131%)
165% 305%
Patient
13
none inferior
STEMI
none
Patient
14
LAD 6 anterior
STEMI
LAD 6 1.5 (1.1–1.9) 2.4 5.2 82% (58–
106%)
135% 280%
Patient
15
LAD 7 anterior
STEMI
LAD 7 4.1 (1.5–5.0) 4.8 11.5 105% (38–
129%)
123% 313%
Patient
16
LAD 6 anterior
STEMI
LAD 6 6.4 (2.3–8.9) 7.9 10.0 100% (36–
139%)
124% 154%
* Affected coronary system (RCA or LCA) excluding segments with visually apparent culprit lesion
† XCA showed heavy thrombus load in PLV branch and PDA (LV branch and PDA not included in 8 segment model for analysis)
§ Culprit lesion CNR in comaprison to all segments within affected coronary system (RCA or LCA) including affected segments
https://doi.org/10.1371/journal.pone.0188292.t003
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Fig 2. CE-MRCVI findings with troponin positive ACS in the LCX. Coronary MRA (A) with troponin positive ACS showed decreased vessel lumen size
of the proximal LCX and first marginal branch (grey arrows). To highlight the relationship between and morphology (A) and CE-MRCVI, images were fused
in a way similar to PET/CT (B). CE-MRCVI displays high signal intensity (red arrows) within the first marginal branch. Corresponding XCA (C) confirmed
CE-MRCVI findings with mid LCX lesion. Short axis delayed enhancement scan shows predominantly transmural myocardial infarction of the mid-
ventricular infero-lateral segment. MRA: magnetic resonance angiography, CE-MRCVI: contrast enhanced magnetic resonance coronary vessel wall
imaging, PET/CT: positron emission tomography/computed tomography.
https://doi.org/10.1371/journal.pone.0188292.g002
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false positive segments in patents with confirmed culprit lesion (n = 8) had lower CNR values
as compared to the corresponding true positive culprit lesion (CNR difference: 2.62, 1.1–13.4).
CE-MRCVI—Relative CNR
Relative CNR values were calculated as ratio between individual segments or culprit lesion for-
mation and the averaged CNR of all corresponding segments of either the left or right coro-
nary system. Similar to the analysis of absolute CNR values, relative CNR values of culprit
lesion formation (CNR 329±153%, 95% CI: 249–409%) were significantly increased as com-
pared to the relative CNR averaged over coronary segments without (96±39%, 95% CI: 88.54–
103.46, p<0.001) and with (130±27%, 95% CI: 116–144%, p<0.001) culprit lesion formation
(Fig 3). Based on a ROC curve analysis a relative CNR threshold of 230 was determined for the
detection of culprit lesion formation in patients with sub-acute myocardial infarction (seg-
ment-wise analysis: area under the curve 0.99, sensitivity 79%, specificity 99%). The use of a
relative cut-off value resulted into true positive detection in 11 out of 14 coronary segments
with culprit lesion formation and true negative classification of 104 of 105 segments without
culprit lesion. The false positive classification of the left main stem (Fig 3, red dot) was
observed in a patient without culprit lesion in XCA (Table 3 Patient 13, inferior STEMI). In
comparison to absolute CNR, the use of relative CNR values yields higher overall specificity
with slightly lower sensitivity (Fig 4). The Bland–Altman analyses demonstrated no significant
differences between repeated enhancement measurements (-9%CNR for intraobserver error,
p>0.05 and −11%CNR for interobserver error p>0.05). Intra-/interobserver agreements with
95% limits of agreement ranging from -35 to 18%CNR and -44 to 22%CNR were acceptable.
Discussion
This study demonstrated the potential of contrast-enhanced magnetic resonance imaging
(CE-MRCVI) for the detection of culprit lesions in patients with sub-acute myocardial infarc-
tion prior to invasive assessment and interventional treatment. CE-MRCVI in 14 patients with
sub-acute myocardial infarction allowed for a direct visualization of culprit lesions in the LAD,
LCX and RCA with high contrast relative to the blood pool and the surrounding tissue. Culprit
lesion CNR significantly exceeded the corresponding values of segments with and without cul-
prit lesion formation.
Non contrast enhanced and contrast-enhanced MR imaging of coronary
atherosclerosis, plaque burden and vascular remodeling
Different non-contrast enhanced and contrast-enhanced MR techniques can be used for the
noninvasive and non-radiation associated characterization of coronary atherosclerosis.
Non-contrast enhanced MR vessel wall imaging (NCE-MRCVI) has shown promise for the
visualization and quantification of coronary vessel wall thickness, vascular remodeling and pla-
que burden in previous studies [12–17,19,20]. Additionally, non-contrast enhanced coronary
plaque imaging is useful for the identification of high intensity plaques (HIP) associated with
intraplaque hemorrhage[24] and/or coronary thrombus [26].
CE-MRCVI based techniques can further add to NCE-MRCVI and together provide com-
prehensive characterization of coronary atherosclerosis. CE-MRCVI currently relies on the
use of non targeted specific gadolinium based contrast agents and enables a morphological
and functional (plaque activity) assessment of atherosclerotic plaques. Non-targeted gadolin-
ium-based contrast agents are approved for clinical use and imaging techniques (LGE-MRI)
for their visualization are relatively robust and typically used for imaging of myocardial infarc-
tion. Clinically approved non-specific gadolinium compounds rapidly extravasate into the
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vessel wall and enhance areas with either increased distribution volume and delayed clearance
(typically fibrosis) or increased endothelial permeability and neovascularization (inflamma-
tion). Previous studies have demonstrated the potential of CE-MRCVI for the characterization
of the coronary artery wall in patients with giant cell arteritis and Takayasu’s arteritis[35–38],
sub-acute myocardial infarction [30] or coronary allograft vasculopathy in children[39]. In the
context of atherosclerosis, serial MR imaging of coronary plaques[30] demonstrated a CNR
increase of up to 40% during the acute phase of myocardial infarction.
The current study demonstrated that quantitative CE-MRCVI correctly identified the cul-
prit lesion location with a sensitivity of 79% and excluded culprit lesion formation with a
Fig 3. Contrast-to-noise ratio of culprit lesion and coronary vessel wall. Contrast to noise ratio (CNR) of segmented culprit lesion in comparison to
segments with and without culprit lesion formation. Absolute CNR values of segmented culprit lesion area (Mean: 9.7, 95% CI: 7.6–11.9), segments with
(Mean: 4.7, 95% CI: 3.4–6.0) and “normal” segments without visual apparent culprit lesion formation (Mean: 2.9, 95% CI: 2.5–3.3) were found to differ
significantly (p<0.05).
https://doi.org/10.1371/journal.pone.0188292.g003
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specificity of 99%. The contrast to noise ratio (CNR) of culprit lesions (9.7±4.1) significantly
exceeded CNR values of segments without culprit lesions (2.9±1.9, p<0.001). The use of rela-
tive CNR values in this study yielded a higher overall specificity with slightly lower sensitivity,
in comparison to absolute CNRs. Compared to previous studies[30] relative CNR values of
culprit lesions were higher, with up to 230% for segments with culprit lesions. In contrast, in a
previous study investigating the chronic “stable” phase 3 month after myocardial infarction
only a moderate increase of 20% was measured. Whereas the latter finding is thought to be
related to plaque volume and fibrosis, the comparatively higher contrast uptake in this study
potentially reflects acute inflammatory changes. These inflammatory processes could represent
Fig 4. Relative contrast-to-noise ratio of culprit lesion and coronary vessel wall. Relative CNR values were calculated as ratio between visually
apparent culprit lesion area, the affected coronary segment (including culprit lesion formation) or “normal” segments without apparent culprit lesion
formation and the averaged CNR of the corresponding entire left or right coronary system. Relative CNR values of segmented culprit lesion area (Mean:
329%, 95% CI: 249–409%), affected coronary segments with culprit lesion (Mean: 130%, 95% CI: 116–144%), and “normal” segments without visual
apparent culprit lesion formation (Mean: 96%, 95% CI: 88.54–103.46) were found to differ significantly (p<0.05). A relative CNR threshold of 230 (red line)
resulted in a true positive detection and localization in 11 out of 14 patients and true exclusion in 104 out of 105 coronary segments. The false positive
classification of the left main stem (red dot) was observed in a patient without culprit lesion in XCA (inferior STEMI).
https://doi.org/10.1371/journal.pone.0188292.g004
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the main contributor for increased coronary plaque contrast uptake due to an increased endo-
thelial permeability and an increased level of angioneogenesis in the extracellular matrix of
inflamed plaques in the sub-acute phase of myocardial infarction.
CE-MRCVI vessel wall imaging could therefore represent a noninvasive technique to 1) dif-
ferentiate between stable and high-risk plaques in patients with coronary atherosclerosis and
2) to monitor disease activity with respect to acute inflammatory changes.
Clinical potential of contrast-enhanced MR imaging of coronary
atherosclerosis
With cardiovascular disease remaining the leading cause of morbidity and mortality in West-
ern industrialized nations and in developing countries [40–45], strategies to prevent acute cor-
onary events and their consequences are of high importance. The majority of acute coronary
events are triggered by plaque rupture or erosion coinciding with vascular thrombosis [4,46].
Fibrous cap thickness (FCT) is one of the most important determinants of plaque vulnerability
with TCFA recognized as a precursor lesion for plaque rupture [3,4]. The PROSPECT (Provid-
ing Regional Observations to Study Predictors of Events in the Coronary Tree) study demon-
strated that TCFA is the highest risk plaque phenotype and the majority of event-related
TCFA where characterized by a larger plaque burden and smaller lumen area [47]. Although
TCFA are considered the highest risk plaque phenotype leading to myocardial infarction,
many plaques rupture without clinical syndromes leading to progressive lumen obstruction
and chronic ischemic heart disease [48]. Several imaging studies confirmed morphological pla-
que changes within a few month gaining or losing “vulnerable” plaque characteristics and
demonstrated a high prevalence of TCFAs at various stages of disease in patients with CAD
[49].
Although emerging imaging modalities like OCT have far surpassed the limits of the early
days of angiography, the invasiveness and peri-procedural radiation exposure limit widespread
clinical use for cardio-vascular risk assessment and treatment monitoring. Similarly, Multi
Detector Computed Tomography (MDCT) and Positron Emission Tomography (PET) have
made great progress in plaque assessment and both techniques have shown very promising
results in identifying vulnerable plaque in patients with cardiovascular disease or acute coro-
nary syndrome. Screening of larger populations or serial imaging after interventional or medi-
cal treatment is however severely hampered by the relatively high radiation exposure.
Because of its non-invasiveness, excellent soft-tissue contrast and ability to visualize the cor-
onary vessel wall, MR is a very promising imaging modality. This study demonstrated that the
information gained from CE-MRCVI has the potential to supplement current risk stratifica-
tion with the ultimate goal to identify and monitor subsets of patients with pan-coronary vul-
nerability benefitting from a more aggressive systemic anti-inflammatory treatment rather
than local or segmental interventional therapy. Despite the transitioning from a focus on indi-
vidual lesions to atherosclerotic disease burden for coronary artery disease risk assessment[9],
individual plaque assessment may proof useful in a subset of patients (e.g. proximal lesions
with large soft plaques and luminal narrowing) to monitor plaque activity and response to
medical treatment.
Limitations
Due to ethical reasons, only patients not eligible for primary PCI were enrolled prospectively
after sub-acute myocardial infarction, thus generalizability of our results is limited by selection
bias with high probability of plaque erosion or rupture. Unlike target specific contrast agents
which are currently restricted to preclinical imaging (e.g. elastin specific molecular probe[50])
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or are limited by a prolonged timespan between contrast administration and imaging (e.g.
ultra-small superparamagnetic particles of iron oxide for inflammation imaging), clinical
approved and wide spread available non-specific compounds rapidly extravasate into the vessel
wall and enhance areas with either fibrosis or increased endothelial permeability and neovas-
cularization (inflammation). Although previous studies support inflammation as decisive con-
tributor for increased contrast uptake within the culprit lesion, differentiation and individual
contribution of plaque size, endothelial permeability and neovascularization remains challeng-
ing with nontargeted MR contrast agents. No comparison between in vivo MRI findings and
invasive methods such as optical coherence tomography (OCT) or intravascular ultrasound
(IVUS) were available as reference standard as part of this study.
Conclusion
This study demonstrated that CE-MR vessel wall imaging has potential for the selective detec-
tion of culprit lesions in patients with acute myocardial infarction. The pronounced contrast
uptake in ruptured plaques may represent a surrogate marker of plaque activity and/or vulner-
ability. Further studies are now warranted to investigate the clinical utility to characterize ath-
erosclerotic plaque activity and vulnerability in a more heterogeneous group of patients with
or without CAD.
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